296 related articles for article (PubMed ID: 15124693)
1. Genetic classification of acute myeloid leukemia (AML).
Haferlach T; Schnittger S; Kern W; Hiddemann W; Schoch C
Ann Hematol; 2004; 83 Suppl 1():S97-100. PubMed ID: 15124693
[TBL] [Abstract][Full Text] [Related]
2. Genes predictive of outcome and novel molecular classification schemes in adult acute myeloid leukemia.
Verhaak RG; Valk PJ
Cancer Treat Res; 2010; 145():67-83. PubMed ID: 20306246
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetics in acute leukemia.
Mrózek K; Heerema NA; Bloomfield CD
Blood Rev; 2004 Jun; 18(2):115-36. PubMed ID: 15010150
[TBL] [Abstract][Full Text] [Related]
4. Delineation of yet unknown cryptic subtelomere aberrations in 50% of acute myeloid leukemia with normal GTG-banding karyotype.
Gross M; Mkrtchyan H; Glaser M; Fricke HJ; Höffken K; Heller A; Weise A; Liehr T
Int J Oncol; 2009 Feb; 34(2):417-23. PubMed ID: 19148476
[TBL] [Abstract][Full Text] [Related]
5. [Combined application of multiplex reverse transcription-polymerase chain reaction and karyotype analysis to detection of clonal chromosomal aberrations in acute myeloid leukemia].
Huang L; Li CR; Zhang H; Sun LS; Liu WL; Zhou JF
Ai Zheng; 2007 Sep; 26(9):1029-33. PubMed ID: 17927867
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetics in acute myeloid leukemia.
Schoch C; Haferlach T
Curr Oncol Rep; 2002 Sep; 4(5):390-7. PubMed ID: 12162912
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of cytogenetic findings in adults with acute myeloid leukemia.
Mrózek K; Heinonen K; Bloomfield CD
Int J Hematol; 2000 Oct; 72(3):261-71. PubMed ID: 11185980
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of 174 de novo acute myelogenous leukemias according to the WHO classification: subtypes, cytogenetic features and FLT3 mutations.
Bao L; Wang X; Ryder J; Ji M; Chen Y; Chen H; Sun H; Yang Y; Du X; Kerzic P; Gross SA; Yao L; Lv L; Fu H; Lin G; Irons RD
Eur J Haematol; 2006 Jul; 77(1):35-45. PubMed ID: 16573742
[TBL] [Abstract][Full Text] [Related]
9. [Classification of AML by morphologic, immunologic and cytogenetic criteria. Review with reference to subtypes in the AML-BFM-87 study].
Creutzig U; Ritter J; Ludwig WD; Harbott J; Löffler H; Schellong G
Klin Padiatr; 1993; 205(4):272-80. PubMed ID: 8377447
[TBL] [Abstract][Full Text] [Related]
10. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
[TBL] [Abstract][Full Text] [Related]
11. Clinical importance of cytogenetics in acute myeloid leukaemia.
Mrózek K; Heinonen K; Bloomfield CD
Best Pract Res Clin Haematol; 2001 Mar; 14(1):19-47. PubMed ID: 11355922
[TBL] [Abstract][Full Text] [Related]
12. Array-based cytogenetic approaches in acute myeloid leukemia: clinical impact and biological insights.
Bullinger L; Fröhling S
Semin Oncol; 2012 Feb; 39(1):37-46. PubMed ID: 22289490
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of cytogenetics in acute myeloid leukemia.
Mrózek K; Heinonen K; de la Chapelle A; Bloomfield CD
Semin Oncol; 1997 Feb; 24(1):17-31. PubMed ID: 9045301
[TBL] [Abstract][Full Text] [Related]
14. Gene expression with prognostic implications in cytogenetically normal acute myeloid leukemia.
Baldus CD; Bullinger L
Semin Oncol; 2008 Aug; 35(4):356-64. PubMed ID: 18692686
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic profile in de novo acute myeloid leukemia with FAB subtypes M0, M1, and M2: a study based on 652 cases analyzed with morphology, cytogenetics, and fluorescence in situ hybridization.
Klaus M; Haferlach T; Schnittger S; Kern W; Hiddemann W; Schoch C
Cancer Genet Cytogenet; 2004 Nov; 155(1):47-56. PubMed ID: 15527902
[TBL] [Abstract][Full Text] [Related]
16. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA
Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of acute myeloblastic leukemia according to the new WHO classification: a different distribution in Central-West Spain.
Chillón CM; García-Sanz R; Balanzategui A; Ramos F; Fernández-Calvo J; Rodríguez MJ; Rodríguez-Salazar MI; Corrales A; Calmuntia MJ; Orfão A; González M; San Miguel JF
Haematologica; 2001 Feb; 86(2):162-6. PubMed ID: 11224485
[TBL] [Abstract][Full Text] [Related]
18. A correlation study of immunophenotypic, cytogenetic, and clinical features of 180 AML patients in China.
Zheng J; Wang X; Hu Y; Yang J; Liu J; He Y; Gong Q; Yao J; Li X; Du W; Huang S
Cytometry B Clin Cytom; 2008 Jan; 74(1):25-9. PubMed ID: 18061959
[TBL] [Abstract][Full Text] [Related]
19. Risk assessment in patients with acute myeloid leukemia and a normal karyotype.
Bienz M; Ludwig M; Leibundgut EO; Mueller BU; Ratschiller D; Solenthaler M; Fey MF; Pabst T
Clin Cancer Res; 2005 Feb; 11(4):1416-24. PubMed ID: 15746041
[TBL] [Abstract][Full Text] [Related]
20. [Morphological, immunological and cytogenetic diagnosis in acute leukemias].
Ratei R; Sperling C; Ludwig WD
Ther Umsch; 1996 Feb; 53(2):88-96. PubMed ID: 8629269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]